Methylenetetrahydrofolate reductase mutation and neural tube defects [18]

Lancet

Volumn 348, Issue 9033, 1996, Pages 1037-1038

  Kirke, P N ^a   Mills, J L ^a   Whitehead, A S ^a   Molloy, A ^a   Scott, J M ^a  

^a HEALTH RESEARCH BOARD   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ALLELE; BLOOD SAMPLING; GENE MUTATION; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PRIORITY JOURNAL;

EID: 0029800387     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64971-9     Document Type: Letter

References (5)

1. DEL Wilcken XL Wang Relevance to spina bifida of mutated methylenetetrahydrofolate reductase Lancet 347 1996 340
2. DL Posey MJ Khoury J Mulinare MJ Adams CY Ou Is mutated MTHFR a risk factor for neural tube defects? Lancet 347 1996 686 687
3. C Papapetrou SA Lynch J Burn YJ Edwards Methylenetetrahydrofolate reductase and neural tube defects Lancet 348 1996 58
4. AS Whitehead P Gallagher JL Mills A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects Q J Med 88 1995 763 766
5. 12 are independent risk factors for neural tube defects Q J Med 86 1993 703 708